<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04364880</url>
  </required_header>
  <id_info>
    <org_study_id>NHRI-EX101-10144NI</org_study_id>
    <nct_id>NCT04364880</nct_id>
  </id_info>
  <brief_title>Neuropsychobiology of Brain Theta-burst Stimulation: A Mind-body Interface for Depression</brief_title>
  <official_title>Neuropsychobiology of Brain Theta-burst Stimulation: A Mind-body Interface for Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Science Council, Taiwan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Science Council, Taiwan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a sham-controlled, randomized trial for patients with MDD to identify the effects of
      TBS on depressive symptomatology, brain function, and peripheral biomarkers in MDD patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a sham-controlled, randomized trial for patients with MDD to identify the effects of
      TBS on depressive symptomatology, brain function (e.g. functional MRI, PET, and qEEG),
      peripheral biomarkers (e.g. candidate genetic expression, neuroendocrine, inflammation, and
      neurotransmissions) in MDD patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2012</start_date>
  <completion_date type="Actual">December 31, 2015</completion_date>
  <primary_completion_date type="Actual">December 31, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hamilton Rating Scale for Depression (HAMD)</measure>
    <time_frame>From Weeks 0 to 24</time_frame>
    <description>HAMD score Changes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Response rate</measure>
    <time_frame>From Weeks 0 to 24</time_frame>
    <description>50% decreases in the Hamilton Rating Scale for Depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Remission rate</measure>
    <time_frame>From Weeks 0 to 24</time_frame>
    <description>Less than 8 points in the Hamilton Rating Scale for Depression</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Depression</condition>
  <condition>Treatment</condition>
  <arm_group>
    <arm_group_label>Theta-burst stimulation (TBS)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Theta-burst stimulation (TBS) is a novel repetitive transcranial magnetic stimulation (rTMS)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham controlled intervention</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>The sham-TBS coil produced a similar sound without a magnetic pulse.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TBS</intervention_name>
    <description>Theta-burst stimulation (TBS) is a novel repetitive transcranial magnetic stimulation (rTMS)</description>
    <arm_group_label>Theta-burst stimulation (TBS)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham</intervention_name>
    <description>The sham-TBS coil produced a similar sound without a magnetic pulse.</description>
    <arm_group_label>Sham controlled intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        (1) the diagnostic criteria of DSM-IV for MDD, (2) between 18 and 70 years old, (3)
        physically healthy on medical history and physical examination and laboratory parameters
        within normal limits, (4) free from antipsychotics, antidepressant, and anticonvulsant
        medications for more than 2 weeks, (5) competent for a full explanation of the study and
        written informed consent is obtained.

        Exclusion Criteria:

        (1) have other current Axis I disorders (except nicotine dependence), patients with
        psychotic disorders, bipolar disorders, organic mental disorders, and a prevailing strong
        suicidal risk were excluded. (2) are pregnant, (3) have history or family history of
        seizure disorder, (4) have known neurological disorders or evidence of central nervous
        system disease based on baseline complete neurological examination, electroencephalography
        and magnetic resonance imaging of the brain, (5) have ferromagnetic material in body or
        close to head (implanted pacemaker or medication pump, metal plate in skull, or metal
        objects in the eye or skull)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kuan-Pin Su, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>China Medical University Hospital</affiliation>
  </overall_official>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 23, 2020</study_first_submitted>
  <study_first_submitted_qc>April 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2020</study_first_posted>
  <last_update_submitted>April 23, 2020</last_update_submitted>
  <last_update_submitted_qc>April 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Science Council, Taiwan</investigator_affiliation>
    <investigator_full_name>Kuan-Pin</investigator_full_name>
    <investigator_title>China Medical University Hospital</investigator_title>
  </responsible_party>
  <keyword>depression</keyword>
  <keyword>transcranial magnetic stimulation</keyword>
  <keyword>theta-burst stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

